News and Press Releases
Bavarian Nordic launches VIMKUNYA in the UK for the Prevention of Chikungunya, for individuals aged 12 years and older
3 September 2025 -- London, UK -- Bavarian Nordic A/S announced today the official UK launch of the VIMKUNYA® chikungunya vaccine (recombinant, absorbed). This follows the recent approval by the...
Category: Drug Discovery, Other, Pharmaceutical
Posted: September 3, 2025
Bavarian Nordic GmbH Fraunhoferstrasse 13 D-82152 Martinsried
Fidia Farmaceutici enters the UK market with the acquisition of Altacor Ltd
Marking another significant milestone in its ongoing international expansion, the Company enters the rapidly-growing UK ophthalmology market, a key therapeutic area for the Group 3 September 2025 -- Abano Terme,...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: September 3, 2025
Resolution Therapeutics announces first patient dosed in Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease
RTX001 is the first engineered Regenerative Macrophage Therapy (RMT) to be evaluated in humans with advanced liver fibrosis First patient has successfully cleared safety period with no serious adverse events...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: September 3, 2025
Centre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh, EH16 4UU
Ryvu Therapeutics Announces Strategic Agreement to Support Clinical Trials for BioNTech’s Investigational Cancer Immunotherapies in Poland
Ryvu to support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clinical programs in Poland Ryvu will leverage its clinical network to...
Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 2, 2025
R&D Center for Innovative Drugs Leona Henryka Sternbacha 2 30-394 Kraków, Poland
New analysis suggests Wegovy (semaglutide injection) 2.4 mg could save the NHS £2.5 billion in healthcare costs and could be estimated to prevent a cardiovascular event every 9 minutes over a period of 15 years in the UK
Gatwick, UK, August 31 2025 – Novo Nordisk today presented data at the European Society of Cardiology (ESC) congress showing that using Wegovy (semaglutide injection) 2.4 mg over a 15-year...
Category:
Posted: September 2, 2025
Aptamer Group Introduces Novel Biomarker Discovery Service
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years Biomarkers are identified based on their ability to translate to drug development strategies. 28 August 2025...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: August 28, 2025
Aptamer group, Suite 2.80 – 2.87, Bio Centre, Innovation Way, Heslington, York, YO10 5NY
Cold Chain Technologies Signals Major APAC Investment with New Hubs and Distributors
Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships. Expanding on its strong base in the region,...
Category: Manufacturing and Packing
Posted: August 27, 2025
NHS diabetes treatment spending reaches £1.92 billion as new medications become available
The NHS Business Services Authority's annual 'Prescribing for Diabetes - England 2015/16 to 2024/25' report reveals that diabetes treatments now account for 15% of all NHS prescription spending, up from...
Category: Clinical Trials
Posted: August 22, 2025
Etihad Cargo Strengthens Connectivity with Expanded Winter Belly-Hold Capacity
Abu Dhabi, UAE – 21 August 2025 – Etihad Cargo, the cargo and logistics arm of Etihad Airways, has announced an expanded winter schedule that will significantly increase belly-hold cargo capacity...
Category: Logistics
Posted: August 21, 2025
Anocca Raises SEK 440 Million to Advance Clinical Trial Targeting Pancreatic Cancer
Financing supports execution of early-stage clinical trials for Anocca’s lead programme VIDAR-1, powered by the Company’s leading-edge R&D platform, to target pancreatic cancer VIDAR-1 is the first non-viral gene-edited TCR-T...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: August 18, 2025
Upperton Pharma Solutions Advancing Oral Vaccines Delivery with Oxford’s Pandemic Sciences Institute
14 August 2025 -- Nottingham, UK -- Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding...
Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: August 14, 2025
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
BOSTON, Aug. 14, 2025 -- Tiziana Life Sciences, Ltd (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human,...
Category: Clinical Trials
Posted: August 14, 2025
Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom
Biocair announces rapid APAC expansion with new office in Shanghai
Shanghai, China: Biocair announced the further expansion of its operations in the APAC region with the opening of a new office in Shanghai, China. The office is collocated with its...
Category: Clinical Trials
Posted: August 14, 2025
Novotech awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit
Novotech, a full-service clinical research organization (CRO), is proud to announce that they have received the highly regarded Veeva Hero award presented at the 2025 Veeva R&D and Quality Summit...
Category: Clinical Trials
Posted: August 14, 2025
Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
Paris, August 14, 2025: The European Medicines Agency has granted orphan designation to rilzabrutinib, a reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD). EMA grants orphan designation...
Category: Clinical Trials
Posted: August 14, 2025
